Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Face | 6 | 2021 | 23 | 3.180 |
Why?
|
| Surgery, Plastic | 4 | 2020 | 11 | 2.750 |
Why?
|
| Search Engine | 2 | 2021 | 7 | 1.510 |
Why?
|
| Nose | 2 | 2020 | 36 | 1.360 |
Why?
|
| Rhinoplasty | 3 | 2022 | 13 | 1.070 |
Why?
|
| Quality of Life | 2 | 2021 | 620 | 1.020 |
Why?
|
| Laryngostenosis | 2 | 2023 | 5 | 0.960 |
Why?
|
| Esthetics | 2 | 2020 | 11 | 0.880 |
Why?
|
| Photography | 2 | 2020 | 15 | 0.860 |
Why?
|
| Skin | 2 | 2020 | 103 | 0.830 |
Why?
|
| Narcotics | 2 | 2020 | 37 | 0.820 |
Why?
|
| Analgesia | 2 | 2020 | 35 | 0.810 |
Why?
|
| Facial Paralysis | 2 | 2021 | 9 | 0.810 |
Why?
|
| Information Seeking Behavior | 1 | 2021 | 5 | 0.780 |
Why?
|
| Internet | 2 | 2022 | 81 | 0.770 |
Why?
|
| Head and Neck Neoplasms | 2 | 2020 | 141 | 0.750 |
Why?
|
| Voice | 1 | 2021 | 4 | 0.750 |
Why?
|
| Spirometry | 1 | 2021 | 11 | 0.750 |
Why?
|
| Blepharoplasty | 1 | 2021 | 2 | 0.750 |
Why?
|
| Cosmetic Techniques | 1 | 2021 | 5 | 0.740 |
Why?
|
| Beauty | 1 | 2020 | 2 | 0.710 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2020 | 2 | 0.710 |
Why?
|
| Cephalometry | 1 | 2020 | 4 | 0.710 |
Why?
|
| Forehead | 1 | 2020 | 3 | 0.700 |
Why?
|
| Patients | 1 | 2020 | 31 | 0.700 |
Why?
|
| Patient Preference | 1 | 2020 | 30 | 0.690 |
Why?
|
| Humans | 30 | 2023 | 26227 | 0.690 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 495 | 0.680 |
Why?
|
| Social Media | 1 | 2020 | 39 | 0.670 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 13 | 0.660 |
Why?
|
| Anesthesia | 1 | 2019 | 31 | 0.660 |
Why?
|
| Biomedical Research | 1 | 2020 | 60 | 0.660 |
Why?
|
| Pain, Postoperative | 2 | 2020 | 309 | 0.650 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2019 | 53 | 0.650 |
Why?
|
| Sex Characteristics | 1 | 2020 | 120 | 0.650 |
Why?
|
| Health Behavior | 1 | 2020 | 153 | 0.640 |
Why?
|
| Endoscopy | 2 | 2019 | 176 | 0.640 |
Why?
|
| Facial Nerve Diseases | 1 | 2018 | 3 | 0.630 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2018 | 4 | 0.630 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2018 | 4 | 0.630 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 186 | 0.630 |
Why?
|
| Sleep | 1 | 2019 | 256 | 0.560 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 160 | 0.560 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 716 | 0.550 |
Why?
|
| Female | 18 | 2022 | 14499 | 0.490 |
Why?
|
| Rhinitis | 3 | 2021 | 142 | 0.450 |
Why?
|
| Sinusitis | 3 | 2021 | 159 | 0.440 |
Why?
|
| Male | 15 | 2021 | 14107 | 0.410 |
Why?
|
| Middle Aged | 12 | 2021 | 8585 | 0.370 |
Why?
|
| Retrospective Studies | 10 | 2020 | 3365 | 0.360 |
Why?
|
| Otolaryngology | 2 | 2021 | 29 | 0.360 |
Why?
|
| Drug Utilization | 2 | 2020 | 22 | 0.340 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 314 | 0.340 |
Why?
|
| SEER Program | 2 | 2019 | 38 | 0.320 |
Why?
|
| Nose Neoplasms | 2 | 2019 | 40 | 0.310 |
Why?
|
| Aged | 9 | 2021 | 8749 | 0.300 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2019 | 62 | 0.300 |
Why?
|
| Adult | 7 | 2021 | 7437 | 0.300 |
Why?
|
| Survival Rate | 4 | 2020 | 322 | 0.270 |
Why?
|
| Head | 2 | 2022 | 23 | 0.210 |
Why?
|
| Nasal Cartilages | 1 | 2022 | 3 | 0.200 |
Why?
|
| Education, Distance | 1 | 2022 | 16 | 0.200 |
Why?
|
| Treatment Outcome | 5 | 2021 | 3381 | 0.190 |
Why?
|
| Mandibular Nerve | 1 | 2021 | 5 | 0.190 |
Why?
|
| Hypoglossal Nerve | 1 | 2021 | 5 | 0.190 |
Why?
|
| Speech | 1 | 2021 | 22 | 0.190 |
Why?
|
| Nerve Transfer | 1 | 2021 | 5 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2021 | 1669 | 0.180 |
Why?
|
| Professional Role | 1 | 2021 | 33 | 0.180 |
Why?
|
| Dyspnea | 1 | 2021 | 39 | 0.180 |
Why?
|
| Glottis | 1 | 2020 | 4 | 0.180 |
Why?
|
| Pain Measurement | 2 | 2020 | 454 | 0.180 |
Why?
|
| Prescriptions | 1 | 2020 | 17 | 0.180 |
Why?
|
| Rejuvenation | 1 | 2020 | 3 | 0.180 |
Why?
|
| Biometry | 1 | 2020 | 6 | 0.180 |
Why?
|
| Tracheostomy | 1 | 2020 | 23 | 0.180 |
Why?
|
| Feminization | 1 | 2020 | 2 | 0.180 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 8 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2020 | 1841 | 0.170 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 37 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 852 | 0.170 |
Why?
|
| Laryngeal Neoplasms | 1 | 2020 | 33 | 0.170 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 80 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 73 | 0.170 |
Why?
|
| Rural Population | 1 | 2020 | 23 | 0.170 |
Why?
|
| Epiglottis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Surgeons | 1 | 2021 | 79 | 0.170 |
Why?
|
| Tongue | 1 | 2019 | 9 | 0.170 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 25 | 0.170 |
Why?
|
| Patient Care Planning | 1 | 2020 | 51 | 0.170 |
Why?
|
| Motivation | 1 | 2020 | 92 | 0.170 |
Why?
|
| Simulation Training | 1 | 2020 | 38 | 0.170 |
Why?
|
| Eosinophilia | 1 | 2019 | 35 | 0.170 |
Why?
|
| Eosinophils | 1 | 2019 | 42 | 0.170 |
Why?
|
| Semicircular Canals | 1 | 2019 | 5 | 0.170 |
Why?
|
| Cranial Fossa, Middle | 1 | 2019 | 4 | 0.170 |
Why?
|
| Temporal Bone | 1 | 2019 | 8 | 0.170 |
Why?
|
| Craniotomy | 1 | 2019 | 20 | 0.160 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2019 | 21 | 0.160 |
Why?
|
| Neck | 1 | 2019 | 27 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 126 | 0.160 |
Why?
|
| Encephalocele | 1 | 2019 | 24 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 99 | 0.160 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 4 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 72 | 0.160 |
Why?
|
| Urban Population | 1 | 2020 | 142 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 81 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2019 | 13 | 0.160 |
Why?
|
| Morphine | 1 | 2019 | 62 | 0.160 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 34 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 84 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 87 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 123 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2020 | 210 | 0.150 |
Why?
|
| Registries | 1 | 2018 | 177 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2021 | 206 | 0.150 |
Why?
|
| Length of Stay | 1 | 2019 | 304 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 311 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 210 | 0.140 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 1075 | 0.130 |
Why?
|
| Young Adult | 1 | 2020 | 1886 | 0.120 |
Why?
|
| Chronic Disease | 3 | 2021 | 419 | 0.110 |
Why?
|
| Prognosis | 3 | 2019 | 758 | 0.100 |
Why?
|
| Pandemics | 2 | 2023 | 239 | 0.080 |
Why?
|
| United States | 3 | 2019 | 1991 | 0.080 |
Why?
|
| Illinois | 2 | 2020 | 230 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 280 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 935 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 26 | 0.050 |
Why?
|
| Nasal Septum | 1 | 2022 | 10 | 0.050 |
Why?
|
| Nasal Lavage | 1 | 2021 | 4 | 0.050 |
Why?
|
| Reading | 1 | 2022 | 40 | 0.050 |
Why?
|
| Mometasone Furoate | 1 | 2021 | 8 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 11 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 11 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 27 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2021 | 38 | 0.050 |
Why?
|
| Prevalence | 1 | 2023 | 435 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 31 | 0.050 |
Why?
|
| Logistic Models | 1 | 2022 | 365 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 520 | 0.050 |
Why?
|
| Neck Dissection | 1 | 2020 | 20 | 0.040 |
Why?
|
| Urbanization | 1 | 2020 | 2 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2020 | 55 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 64 | 0.040 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 29 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 78 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2019 | 10 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 45 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 332 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 194 | 0.040 |
Why?
|
| Paranasal Sinuses | 1 | 2019 | 60 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 717 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1735 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1145 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4670 | 0.020 |
Why?
|